Company intelligence / Profile preview

Vegenics Pty Ltd

Melbourne, Victoria, Australiatryveganic.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Vegenics developed a pipeline of monoclonal antibodies and peptide antagonists targeting VEGF-C/VEGF-D for cancer therapy and other indications. Its lead program VGX‑100 targeted VEGF‑C. The company’s technology was considered high-potential but most programs were preclinical or early clinical at the time it was acquired by Circadian Technologies in July 2008. Some assets were licensed to third parties for further development, including gene therapy products with Ark Therapeutics.

Therapeutic areas
OncologyCardiovascularOphthalmology
Modalities
Monoclonal antibodies (mAbs)Peptides
Industry
Biotech
02

Partnerships

CoGenesys – exclusive worldwide rights to human mAbs against VEGF-CEvoGenix – collaboration on antibody humanization/optimization for anti–VEGF-D therapeuticsArk Therapeutics – licensee of gene therapy product using Vegenics’ IP in the UK

Beyond the preview

Go deeper on Vegenics Pty Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vegenics Pty Ltd.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call